The breast, bowel and cervical screening programmes require consultant pathologists and other specialist laboratory staff to take part in ‘external quality assessment’ or EQA. But what is EQA exactly?
NHS Cervical Screening Programme
Public Health England doesn’t directly train people how to carry out screening in the NHS. We’d love to visit you all but sadly don’t have the resources to do this.
Evidence shows that human papillomavirus (HPV) testing is a better way of identifying women at risk of cervical cancer than the cytology (smear) test that examines cells under a microscope.
Cervical screening saves an estimated 5,000 lives a year by detecting abnormalities of the cervix early and referring women for effective treatment.
Cervical screening prevents cancer by detecting abnormalities of the cervix and referring women for potential treatment.
We are pleased to publish the sample taker training guidance for the NHS Cervical Screening Programme, replacing the previous publication ‘A Resource Pack for Trainers’ (April 2006).
PHE screening team members and clinicians attended the 40th European Congress of Cytology in Liverpool.
The NHS Cervical Screening Programme in England relies on laboratories to screen and report on cervical cytology samples (3.2 million were examined in 2014-15).
The London Screening Quality Assurance Services (SQAS) team held a meeting for London QA cytology, colposcopy and hospital-based programme coordinators.
The 11 national screening programmes cover a wide variety of conditions, age ranges and screening tests.